Generation of an infectious clone of duck enteritis virus (DEV) and of a vectored DEV expressing hemagglutinin of H5N1 avian influenza virus

Virus Research

Volumn 159, Issue 1, 2011, Pages 23-31

  Wang, Jichun ^a   Osterrieder, Nikolaus ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

BAC; DEV; GC; H5N1 AIV; Vectored vaccine

Indexed keywords

UNCLASSIFIED DRUG; VECTORED VACCINE; VIRUS GLYCOPROTEIN; VIRUS HEMAGGLUTININ; VIRUS VACCINE;

ALPHAHERPESVIRINAE; ANATID HERPESVIRUS 1; ANIMAL CELL; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CHICKEN; DUCK; DUCK ENTERITIS VIRUS; EMBRYO; ESCHERICHIA COLI; INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS ISOLATION; VIRUS RECOMBINANT;

ANIMALS; CELL LINE; CHROMOSOMES, ARTIFICIAL, BACTERIAL; ESCHERICHIA COLI; GENETIC ENGINEERING; GENETIC VECTORS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; MARDIVIRUS; PLAQUE ASSAY; RECOMBINATION, GENETIC; VACCINES, SYNTHETIC; VIRAL LOAD; VIRULENCE;

AVIAN INFLUENZA VIRUS; BACTERIA (MICROORGANISMS); DUCK ENTERITIS VIRUS; ESCHERICHIA COLI;

EID: 79957591806     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.04.013     Document Type: Article

References (68)

1. Adamiak B., Trybala E., Mardberg K., Johansson M., Liljeqvist J., Olofsson S., Grabowska A., Bienkowska-Szewczyk K., Szewczyk B., Bergstrom T. Human antibodies to herpes simplex virus type 1 glycoprotein C are neutralizing and target the heparan sulfate-binding domain. Virology 2010, 400(2):197-206.
2. Adler H., Messerle M., Wagner M., Koszinowski U. Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J. Virol. 2000, 74(15):6964-6974.
3. Awasthi S., Lubinski J., Friedman H. Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine. Vaccine 2009, 27(49):6845-6853.
4. Azab W., Tsujimura K., Maeda K., Kobayashi K., Mohamed Y., Kato K., Matsumura T., Akashi H. Glycoprotein C of equine herpesvirus 4 plays a role in viral binding to cell surface heparan sulfate. Virus Res. 2010, 151(1):1-9.
5. Boussif O., Lezoualc'h F., Zanta M., Mergny M., Scherman D., Demeneix B., Behr J. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. U.S.A. 1995, 92(16):7297-7301.
6. Chang W., Barry P. Cloning of the full-length rhesus cytomegalovirus genome as an infectious and self-excisable bacterial artificial chromosome for analysis of viral pathogenesis. J. Virol. 2003, 77(9):5073-5083.
7. Ducatez M.F., Webster R.G., Webby R.J. Animal influenza epidemiology. Vaccine 2008, 12(26 Suppl 4):D67-D69.
8. Herold B., WuDunn D., Soltys N., Spear P. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 1991, 65(3):1090-1098.
9. Hocknell P., Wiley R., Wang X., Evans T., Bowers W., Hanke T., Federoff H., Dewhurst S. Expression of human immunodeficiency virus type 1 gp120 from herpes simplex virus type 1-derived amplicons results in potent, specific, and durable cellular and humoral immune responses. J. Virol. 2002, 76(11):5565-5580.
10. Hook L., Huang J., Jiang M., Hodinka R., Friedman H. Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E. J. Virol. 2008, 82(14):6935-6941.
11. Huemer H., Nowotny N., Crabb B., Meyer H., Hübert P. gp13 (EHV-gC): a complement receptor induced by equine herpesviruses. Virus Res. 1995, 37(2):113-126.
12. Huemer H., Wang Y., Garred P., Koistinen V., Oppermann S. Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein. Immunology 1993, 79(4):639-647.
13. Jarosinski K., Margulis N., Kamil J., Spatz S., Nair V., Osterrieder N. Horizontal transmission of Marek's disease virus requires US2, the UL13 protein kinase, and gC. J. Virol. 2007, 81(19):10575-10587.
14. Jarosinski K., Osterrieder N. Further analysis of Marek's disease virus horizontal transmission confirms that U(L)44 (gC) and U(L)13 protein kinase activity are essential, while U(S)2 is nonessential. J. Virol. 2010, 84(15):7911-7916.
15. Johnson D., McDermott M., Chrisp C., Glorioso J. Pathogenicity in mice of herpes simplex virus type 2 mutants unable to express glycoprotein C. J. Virol. 1986, 58(1):36-42.
16. Kaleta E., Kuczka A., Kühnhold A., Bunzenthal C., Bönner B., Hanka K., Redmann T., Yilmaz A. Outbreak of duck plague (duck herpesvirus enteritis) in numerous species of captive ducks and geese in temporal conjunction with enforced biosecurity (in-house keeping) due to the threat of avian influenza A virus of the subtype Asia H5N1. Dtsch. Tierarztl. Wochenschr. 2007, 114(1):3-11.
17. Keawcharoen J., van Riel D., van Amerongen G., Bestebroer T., Beyer W., van Lavieren R., Osterhaus A., Fouchier R., Kuiken T. Wild ducks as long-distance vectors of highly pathogenic avian influenza virus (H5N1). Emerg. Infect. Dis. 2008, 14(4):600-607.
18. Keymer I., Gough R. Duck virus enteritis (anatid herpesvirus infection) in mute swans (Cygnus olor). Avian Pathol. 1986, 15(1):161-170.
19. Kim J., Negovetich N., Forrest H., Webster R. Ducks: the "Trojan horses" of H5N1 influenza. Influenza Other Respir. Viruses 2009, 3(4):121-128.
20. Kothlow S., Mannes N., Schaerer B., Rebeski D., Kaspers B., Schultz U. Characterization of duck leucocytes by monoclonal antibodies. Dev. Comp. Immunol. 2005, 29(8):733-748.
21. Lee E., Yu D., Martinez de Velasco J., Tessarollo L., Swing D., Court D., Jenkins N., Copeland N. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 2001, 73(1):56-65.
22. Leibovitz L. Progress report: duck plague surveillance of American Anseriformes. Wildl. Dis. 1968, 4(3):87-91.
23. Li Y., Huang B., Ma X., Wu J., Li F., Ai W., Song M., Yang H. Molecular characterization of the genome of duck enteritis virus. Virology 2009, 391(2):151-161.
24. Livingston J., Sutherland M., Friedman H., Pryzdial E. Herpes simplex virus type 1-encoded glycoprotein C contributes to direct coagulation factor X-virus binding. Biochem. J. 2006, 393(Pt 2):529-535.
25. Maeda K., Hayashi S., Tanioka Y., Matsumoto Y., Otsuka H. Pseudorabies virus (PRV) is protected from complement attack by cellular factors and glycoprotein C (gC). Virus Res. 2002, 84(1-2):79-87.
26. Mayrhofer J., Coulibaly S., Hessel A., Holzer G., Schwendinger M., Brühl P., Gerencer M., Crowe B., Shuo S., Hong W., Tan Y., Dietrich B., Sabarth N., Savidis-Dacho H., Kistner O., Barrett P., Falkner F. Nonreplicating vaccinia virus vectors expressing the H5 influenza virus hemagglutinin produced in modified Vero cells induce robust protection. J. Virol. 2009, 83(10):5192-5203.
27. Messerle M., Crnkovic I., Hammerschmidt W., Ziegler H., Koszinowski U. Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc. Natl. Acad. Sci. U.S.A. 1997, 94(26):14759-14763.
28. Mettenleiter T., Kern H., Rauh I. Isolation of a viable herpesvirus (pseudorabies virus) mutant specifically lacking all four known nonessential glycoproteins. Virology 1990, 179(1):498-503.
29. Moffat J., Zerboni L., Kinchington P., Grose C., Kaneshima H., Arvin A. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J. Virol. 1998, 72(2):965-974.
30. Morgan R., Cantello J., McDermott C. Transfection of chicken embryo fibroblasts with Marek's disease virus DNA. Avian Dis. 1990, 34(2):345-351.
31. Muyrers J., Zhang Y., Testa G., Stewart A. Rapid modification of bacterial artificial chromosomes by ET-recombination. Nucleic Acids Res. 1999, 27(6).
32. Narayanan K., Williamson R., Zhang Y., Stewart A., Ioannou P. Efficient and precise engineering of a 200kb beta-globin human/bacterial artificial chromosome in E. coli DH10B using an inducible homologous recombination system. Gene Ther. 1999, 6(3):442-447.
33. Neumann G., Chen H., Gao G., Shu Y., Kawaoka Y. H5N1 influenza viruses: outbreaks and biological properties. Cell Res. 2010, 20(1):51-61.
34. Oh H., Akerström S., Shen S., Bereczky S., Karlberg H., Klingström J., Lal S., Mirazimi A., Tan Y. An antibody against a novel and conserved epitope in the hemagglutinin 1 subunit neutralizes numerous H5N1 influenza viruses. J. Virol. 2010, 84(16):8275-8286.
35. Osterrieder N. Construction and characterization of an equine herpesvirus 1 glycoprotein C negative mutant. Virus Res. 1999, 59(2):165-177.
36. Osterrieder N., Schumacher D., Trapp S., Beer M., von Einem J., Tischer K. Establishment and use of infectious bacterial artificial chromosome (BAC) DNA clones of animal herpesviruses. Berl. Munch. Tierarztl. Wochenschr. 2003, 116(9-10):373-380.
37. Pavlova S., Veits J., Blohm U., Maresch C., Mettenleiter T., Fuchs W. In vitro and in vivo characterization of glycoprotein C-deleted infectious laryngotracheitis virus. J. Gen. Virol. 2010, 91(Pt 4):847-857.
38. Peiris J., de Jong M., Guan Y. Avian influenza virus (H5N1): a threat to human health. Clin. Microbiol. Rev. 2007, 20(2):243-267.
39. Petherbridge L., Xu H., Zhao Y., Smith L., Simpson J., Baigent S., Nair V. Cloning of Gallid herpesvirus 3 (Marek's disease virus serotype-2) genome as infectious bacterial artificial chromosomes for analysis of viral gene functions. J. Virol. Methods 2009, 158(1-2):11-17.
40. Reperant L., Fuckar N., Osterhaus A., Dobson A., Kuiken T. Spatial and temporal association of outbreaks of H5N1 influenza virus infection in wild birds with the 0 degrees C isotherm. PLoS Pathog. 2010, 6(4):e1000854.
41. Rosas C., Goodman L., von Einem J., Osterrieder N. Equine herpesvirus type 1 modified live virus vaccines: quo vaditis?. Exp. Rev. Vac. 2006, 5(1):119-131.
42. Rosas C., König P., Beer M., Dubovi E., Tischer B., Osterrieder N. Evaluation of the vaccine potential of an equine herpesvirus type 1 vector expressing bovine viral diarrhea virus structural proteins. J. Gen. Virol. 2007, 88(Pt 3)(Pt 3):748-757.
43. Rosas C., Tischer B., Perkins G., Wagner B., Goodman L., Osterrieder N. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV). Virus Res. 2007, 125(1):69-78.
44. Rosas C., Van de Walle G., Metzger S., Hoelzer K., Dubovi E., Kim S., Parrish C., Osterrieder N. Evaluation of a vectored equine herpesvirus type 1 (EHV-1) vaccine expressing H3 haemagglutinin in the protection of dogs against canine influenza. Vaccine 2008, 26(19):2335-2343.
45. Rudolph J., O'Callaghan D., Osterrieder N. Cloning of the genomes of equine herpesvirus type1 (EHV-1) strains KyA and racL11 as bacterial artificial chromosomes (BAC). J. Vet. Med. B, Infect. Dis. Vet. Public Health 2002, 49:31-36.
46. Rue C., Ryan P. Pseudorabies virus glycoprotein C attachment-proficient revertants isolated through a simple, targeted mutagenesis scheme. J. Virol. Methods 2008, 151(1):101-106.
47. Saksena M., Wakisaka H., Tijono B., Boadle R., Rixon F., Takahashi H., AL C. Herpes simplex virus type 1 accumulation, envelopment, and exit in growth cones and varicosities in mid-distal regions of axons. J. Virol. 2006, 80(7):3592-3606.
48. Scheper T., Saschenbrecker S., Steinhagen K., Sauerbrei A., Suer W., Meyer W., Schlumberger W., Wandinger K. The glycoproteins C and G are equivalent target antigens for the determination of herpes simplex virus type 1-specific antibodies. J. Virol. Methods 2010, 166(1-2):42-47.
49. Schumacher D., Tischer B., Fuchs W., Osterrieder N. Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant. J. Virol. 2000, 74(23):11088-11098.
50. Seyboldt C., Granzow H., Osterrieder N. Equine herpesvirus 1 (EHV-1) glycoprotein M: effect of deletions of transmembrane domains. Virology 2000, 278(2):477-489.
51. Shizuya H., Birren B., Kim U., Mancino V., Slepak T., Tachiiri Y., Simon M. Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector. Proc. Natl. Acad. Sci. U.S.A. 1992, 89(18):8794-8797.
52. Smith G., Enquist L. Construction and transposon mutagenesis in Escherichia coli of a full-length infectious clone of pseudorabies virus, an alphaherpesvirus. J. Virol. 1999, 73(8):6405-6414.
53. Smith G., Enquist L. A self-recombining bacterial artificial chromosome and its application for analysis of herpesvirus pathogenesis. Proc. Natl. Acad. Sci. U.S.A. 2000, 97(9):4873-4878.
54. Stokes A., Corteyn A., Pullen L., Doel T., Meredith D., Killington R., Halliburton I., Whittaker G., Wheldon L., Nicolson L., Onions D., Allen G., Murray P. Studies on glycoprotein 13 (gp13) of equid herpesvirus 1 using affinity-purified gp13, glycoprotein-specific monoclonal antibodies and synthetic peptides in a hamster model. J. Gen. Virol. 1991, 72(Pt 4):923-931.
55. Storlie J., Carpenter J., Jackson W., Grose C. Discordant varicella-zoster virus glycoprotein C expression and localization between cultured cells and human skin vesicles. Virology 2008, 382(2):171-181.
56. Sturm-Ramirez K., Hulse-Post D., Govorkova E., Humberd J., Seiler P., Puthavathana P., Buranathai C., Nguyen T., Chaisingh A., Long H., Naipospos T., Chen H., Ellis T., Guan Y., Peiris J., Webster R. Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia?. J. Virol. 2005, 79(17):11269-11279.
57. Suchodolski P., Izumiya Y., Lupiani B., Ajithdoss D., Gilad O., Lee L., Kung H., Reddy S. Homodimerization of Marek's disease virus-encoded Meq protein is not sufficient for transformation of lymphocytes in chickens. J. Virol. 2009, 83(2):859-869.
58. Tischer B., Schumacher D., Chabanne-Vautherot D., Zelnik V., Vautherot J., Osterrieder N. High-level expression of Marek's disease virus glycoprotein C is detrimental to virus growth in vitro. J. Virol. 2005, 79(10):5889-5899.
59. Tischer B., Smith G., Osterrieder N. En passant mutagenesis: a two step markerless red recombination system. Methods Mol. Biol. 2010, 634:421-430.
60. Tischer B., von Einem J., Kaufer B., Osterrieder N. Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. Biotechniques 2006, 40(2):191-197.
61. Trybala E., Svennerholm B., Bergström T., Olofsson S., Jeansson S., Goodman J. Herpes simplex virus type 1-induced hemagglutination: glycoprotein C mediates virus binding to erythrocyte surface heparan sulfate. J. Virol. 1993, 67(3):1278-1285.
62. Tsukamoto K., Kojima C., Komori Y., Tanimura N., Mase M., Yamaguchi S. Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2. Virology 1999, 257(2):352-362.
63. Tsukamoto K., Saito S., Saeki S., Sato T., Tanimura N., Isobe T., Mase M., Imada T., Yuasa N., Yamaguchi S. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens. J. Virol. 2002, 76(11):5637-5645.
64. Vijaykrishna D., Bahl J., Riley S., Duan L., Zhang J., Chen H., Peiris J., Smith G., Guan Y. Evolutionary dynamics and emergence of panzootic H5N1 influenza viruses. PLoS Pathog. 2008, 4(9):e1000161.
65. Willemse M., Chalmers W., Cronenberg A., Pfundt R., Strijdveen I., Sondermeijer P. The gene downstream of the gC homologue in feline herpes virus type 1 is involved in the expression of virulence. J. Gen. Virol. 1994, 75(Pt 11):3107-3116.
66. Wobeser G. Experimental duck plague in blue-winged teal and Canada geese. J. Wildl. Dis. 1987, 23(3):368-375.
67. Yu D., Smith G., Enquist L., Shenk T. Construction of a self-excisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene. J. Virol. 2002, 76(5):2316-2328.
68. Zhou X., Wang D., Xiong J., Zhang P., Li Y., She R. Protection of chickens, with or without maternal antibodies, against IBDV infection by a recombinant IBDV-VP2 protein. Vaccine 2010, 28(23):3990-3996.